Kama Gulsen 4
4 · Bionano Genomics, Inc. · Filed Sep 20, 2023
Insider Transaction Report
Form 4
Kama Gulsen
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-09-18+106,000→ 106,000 totalExercise: $3.00Exp: 2033-09-18→ Common Stock (106,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest and become exercisable on September 11, 2024, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from September 11, 2024, subject to Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan, as amended) through each such applicable vesting date and the terms of the Company's 2020 Inducement Plan, as amended.